Related Experiment Video
Updated: Jul 31, 2025

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
Rapid, High-Throughput Single-Cell Multiplex In Situ Tagging (MIST) Analysis of Immunological Disease with Machine
Liwei Yang1, Pratik Dutta2, Ramana V Davuluri2
1Multiplex Biotechnology Laboratory, Department of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, New York 11794, United States.
New single-cell multiplex in situ tagging (scMIST) technology analyzes T cells for rapid immunological disorder detection. This approach accurately distinguishes sepsis from normal inflammation, paving the way for advanced diagnostics.
Area of Science:
- Immunology
- Single-cell analysis
- Biotechnology
Background:
- Immune responses involve complex cytokine cascades, leading to inflammation or sepsis-induced organ damage.
- Current diagnostic methods for immunological disorders, relying on serum cytokines, lack accuracy and struggle to differentiate normal inflammation from sepsis.
- There is a critical need for precise diagnostic tools to identify sepsis and other immunological conditions.
Purpose of the Study:
- To develop and validate a novel approach for detecting immunological disorders using single-cell analysis.
- To assess the capability of single-cell multiplex in situ tagging (scMIST) technology for ultrahigh-multiplex T cell analysis.
- To differentiate between normal inflammation and sepsis using T cell profiling.
Main Methods:
- Employed single-cell multiplex in situ tagging (scMIST) technology for simultaneous detection of 46 markers and cytokines from individual T cells.
- Utilized a cecal ligation and puncture (CLP) sepsis model in mice, collecting T cells from survivors and non-survivors.
- Applied a random forest machine learning model for T cell classification and group prediction.
Main Results:
- scMIST successfully captured T cell features and dynamics during sepsis progression and recovery.
- T cell markers exhibited distinct dynamics and cytokine levels compared to peripheral blood cytokines.
- The machine learning model achieved 94% accuracy in predicting mouse groups (sepsis vs. survival) based on single T cell data.
Conclusions:
- Single-cell multiplex in situ tagging (scMIST) offers a rapid and accurate method for analyzing T cell responses in immunological disorders.
- This T cell-based approach demonstrates superior potential in distinguishing sepsis from normal inflammation compared to traditional methods.
- The study pioneers single-cell omics for diagnostics and holds broad applicability for human disease diagnosis and research.
More Related Videos
07:46Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
08:18Multiplexed Barcoding Image Analysis for Immunoprofiling and Spatial Mapping Characterization in the Single-Cell Analysis of Paraffin Tissue Samples
Published on: April 7, 2023